AI assistant
Sending…
Anterix Inc. — Director's Dealing 2021
Jan 9, 2021
33018_dirs_2021-01-08_58ca4e26-c140-460d-87a8-98760e083075.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Anterix Inc. (ATEX)
CIK: 0001304492
Period of Report: 2021-01-07
Reporting Person: Ashe Gena L (General Counsel & Secretary)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-01-07 | Stock Option (Right to Buy) | $32.90 | A | 849 | Acquired | 2031-01-07 | Common Stock (849) | Direct |
Footnotes
F1: The option shares vest and become exercisable in 2 equal annual installments measured from January 7, 2021.
More from Anterix Inc.
Fund Information / Factsheet
2026
Apr 21
Regulatory Filings
2026
Apr 21
Capital/Financing Update
2026
Apr 6
Regulatory Filings
2026
Apr 1
Earnings Release
2026
Feb 11
Interim / Quarterly Report
2026
Feb 11
Regulatory Filings
2026
Feb 2
Major Shareholding Notification
2026
Jan 30
Board/Management Information
2026
Jan 7
Director's Dealing
2025
Dec 19